Latest filing published 14 Aug 2025 for AMEDISYS INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Molly Joel Coye, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Aetna Inc /PA/ and Amedisys Inc. The record holds 16 filings, for trades running from 22 February 2016 to 14 August 2025.
The open-market record consists of 4 sales worth €460k, with no purchase. Besides market trades, the filings include 7 share grants and 3 option exercises.
On 14 August 2025 came the latest disclosure, a transaction in Amedisys Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations